IgE-Mediated Reaction to Metamizole: Evaluation of a Patient with Severe Anaphylaxis

dc.contributor.authorArslan, Sevket
dc.contributor.authorUcar, Ramazan
dc.contributor.authorCaliskaner, Ahmet Zafer
dc.date.accessioned2024-02-23T14:41:04Z
dc.date.available2024-02-23T14:41:04Z
dc.date.issued2016
dc.departmentNEÜen_US
dc.description.abstractMetamizole, a non-steroidal anti-inflammatory drug with weak anti-inflammatory and spasmolytic effects, is used as an analgesic and antipyretic agent. Many adverse reactions to metamizole, such as early or late-onset systemic reactions and bone marrow suppression, have been identified. In this report, we present a case of systemic reaction after the application of parenteral metamizole (Novalgin (R) ampoule; Sanofi Aventis, Istanbul, Turkey) and discuss the mechanism underlying the reaction.en_US
dc.identifier.doi10.5152/eurasianjmed.2015.0024
dc.identifier.endpage148en_US
dc.identifier.issn1308-8742
dc.identifier.issue2en_US
dc.identifier.pmid27551180en_US
dc.identifier.scopus2-s2.0-84979263812en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage145en_US
dc.identifier.urihttps://doi.org/10.5152/eurasianjmed.2015.0024
dc.identifier.urihttps://hdl.handle.net/20.500.12452/16696
dc.identifier.volume48en_US
dc.identifier.wosWOS:000383256800014en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.ispartofEurasian Journal Of Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAbdominal Painen_US
dc.subjectMetamizoleen_US
dc.subjectSystemic Reactionsen_US
dc.titleIgE-Mediated Reaction to Metamizole: Evaluation of a Patient with Severe Anaphylaxisen_US
dc.typeArticleen_US

Dosyalar